Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study
Dongre S, Langade D, Bhattacharyya S
BioMed research international · 48 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2015-01-01 · Biomed Res Int · vol. 2015 · págs. 1–9
- Editorial
- Hindawi Publishing Corporation
- Citado
- 84 citas · más que el 84% de estudios similares · 1.9× el promedio de su campo
- Referencias
- 25 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Sexual function and dysfunction studies · Phytochemicals and Medicinal Plants · Menopause: Health Impacts and Treatments
- Palabras clave
- Orgasm, Algorithm, Placebo, Sexual function, Medicine, Sexual dysfunction, Mathematics, Internal medicine
- MeSH
- humans, withania, plants, medicinal, plant extracts, treatment outcome, phytotherapy, pilot projects, double-blind method, sexual behavior, sexual dysfunctions, psychological, orgasm, adult, middle aged, female, young adult
3 autores
- Swati Dongre
- Deepak Langade🇮🇳 · autor de correspondenciaMahatma Gandhi Mission's Dental College and Hospital
- Sauvik Bhattacharyya
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Many women experience sexual dysfunction where there are orgasm disorders and sexual difficulties. Ashwagandha (Withania somnifera) is a herb known to improve the body's physical and psychological condition.
Objective
The purpose of the study was to determine the efficacy and safety of a high-concentration ashwagandha root extract (HCARE) supplementation for improving sexual function in healthy females.
Methods
In this pilot study, 50 study subjects were randomized to either (i) HCARE-treated group or (ii) placebo- (starch-) treated group. The subjects consumed either HCARE or placebo capsules of 300mg twice daily for 8 weeks. Sexual function was assessed using two psychometric scales, the Female Sexual Function Index (FSFI) Questionnaire and the Female Sexual Distress Scale (FSDS), and by the number of total and successful sexual encounters.
Results
The analysis indicates that treatment with HCARE leads to significantly higher improvement, relative to placebo, in the FSFI Total score (p < 0.001), FSFI domain score for "arousal" (p < 0.001), "lubrication" (p < 0.001), "orgasm" (p = 0.004), and "satisfaction" (p < 0.001), and also FSDS score (p < 0.001) and the number of successful sexual encounters (p < 0.001) at the end of the treatment.
Conclusions
This study demonstrated that oral administration of HCARE may improve sexual function in healthy women. The present study is registered in the Clinical Trial Registry, Government of India, with a number CTRI/2015/07/006045.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.